367 related articles for article (PubMed ID: 1320736)
1. The declining risk of post-transfusion hepatitis C virus infection.
Donahue JG; Muñoz A; Ness PM; Brown DE; Yawn DH; McAllister HA; Reitz BA; Nelson KE
N Engl J Med; 1992 Aug; 327(6):369-73. PubMed ID: 1320736
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays.
Aach RD; Stevens CE; Hollinger FB; Mosley JW; Peterson DA; Taylor PE; Johnson RG; Barbosa LH; Nemo GJ
N Engl J Med; 1991 Nov; 325(19):1325-9. PubMed ID: 1656258
[TBL] [Abstract][Full Text] [Related]
4. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
Chung HT; Lee JS; Lok AS
Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
[TBL] [Abstract][Full Text] [Related]
5. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.
Alter HJ; Purcell RH; Shih JW; Melpolder JC; Houghton M; Choo QL; Kuo G
N Engl J Med; 1989 Nov; 321(22):1494-500. PubMed ID: 2509915
[TBL] [Abstract][Full Text] [Related]
6. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease.
Alter HJ; Nakatsuji Y; Melpolder J; Wages J; Wesley R; Shih JW; Kim JP
N Engl J Med; 1997 Mar; 336(11):747-54. PubMed ID: 9052652
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening.
Vogt M; Lang T; Frösner G; Klingler C; Sendl AF; Zeller A; Wiebecke B; Langer B; Meisner H; Hess J
N Engl J Med; 1999 Sep; 341(12):866-70. PubMed ID: 10498458
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of hepatitis B virus markers for surrogate testing of hepatitis C].
Ohto H; Nomura H; Ohmura K; Ishijima A; Okazaki S
Rinsho Byori; 1991 Jan; 39(1):14-7. PubMed ID: 1848910
[TBL] [Abstract][Full Text] [Related]
9. [Massive and multi-transfusions in polytraumatized patients: long-term serologic markers of hepatitis B, hepatitis C and AIDS].
Schneck HJ; Dobler G; Hundelshausen B; Nathrath M; Drescher M
Infusionstherapie; 1991 Oct; 18(5):248-55. PubMed ID: 1663086
[TBL] [Abstract][Full Text] [Related]
10. Post transfusion hepatitis: comparison between homologous and autologous blood transfusion.
Meraviglia P; Viganï P; Gubertini G; Santoli E; Santoli C; Cargnel A
Eur J Med; 1992 May; 1(2):75-9. PubMed ID: 1342376
[TBL] [Abstract][Full Text] [Related]
11. Risk of transfusion-transmitted hepatitis C virus in a tertiary hospital in Nigeria.
Imarengiaye CO; Enosolease ME; Iribhogbe PE; Ehigiegba AE
Public Health; 2006 Mar; 120(3):274-8. PubMed ID: 16364383
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
[TBL] [Abstract][Full Text] [Related]
13. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of antibodies to hepatitis C virus in transfused children with cancer.
Monteleone PM; Andrzejewski C; Kelleher JF
Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):309-13. PubMed ID: 7978047
[TBL] [Abstract][Full Text] [Related]
15. Estimated risk of transmission of hepatitis C virus by blood transfusion.
Koerner K; Cardoso M; Dengler T; Kerowgan M; Kubanek B
Vox Sang; 1998; 74(4):213-6. PubMed ID: 9691400
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors of hepatitis C infection after cardiac surgery in childhood before and after blood donor screening.
Vogt M; Mühlbauer F; Braun SL; Lang T; Busch R; Lange R; Frösner G; Hess J
Infection; 2004 Jun; 32(3):134-7. PubMed ID: 15188071
[TBL] [Abstract][Full Text] [Related]
17. [ALAT and viral RNA as risk factors in 68 blood donors with anti-hepatitis C antibodies].
Tullen E; De Saussure P; Soulier-Lauper M
Schweiz Med Wochenschr; 1993 Jan; 123(3):57-61. PubMed ID: 7678939
[TBL] [Abstract][Full Text] [Related]
18. [Prevention of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
Infusionsther Transfusionsmed; 1992 Jun; 19(3):157-9. PubMed ID: 1379861
[TBL] [Abstract][Full Text] [Related]
19. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
20. Safety of the blood supply. Surrogate testing and transmission of hepatitis C in patients after massive transfusion.
Morris JA; Wilcox TR; Reed GW; Hunter EB; Wallas CH; Steane EA; Shotts SD; Vitsky JL
Ann Surg; 1994 May; 219(5):517-25; discussion 525-6. PubMed ID: 7514394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]